510(k) Process Issues Surface At FDA Appropriations Hearings

Deputy FDA Commissioner Joshua Sharfstein told Congress he and incoming Commissioner Margaret Hamburg will be taking a look at the 510(k) clearance process to determine whether it is truly flawed, or just misunderstood